Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Archives of Disease in Childhood|March 1, 1996
An intensive multiagent chemotherapy regimen for brain tumours occurring in very young childrenL S Lashford, R H Campbell, H R Gattamaneni, et al.
British Journal of Cancer|March 31, 1999
Ifosfamide/etoposide alternating with high-dose methotrexate: evaluation of a chemotherapy regimen for poor-risk osteosarcomaM P Michelagnoli, I J Lewis, H R Gattamaneni, et al.
European Journal of Nuclear Medicine|January 1, 1991
Dosimetry of iodine 131 metaiodobenzylguanidine for treatment of resistant neuroblastoma: results of a UK studyS L Fielding, M A Flower, D Ackery, et al.
Expert Reviews in Molecular Medicine|February 28, 2004
New perspectives for cancer chemotherapy by genetic protection of haematopoietic cellsC Baum, L J Fairbairn, M Hildinger, et al.
Gene Therapy|April 11, 2000
Development of synthetic promoters for radiation-mediated gene therapyB Marples, S D Scott, J H Hendry, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 1, 1992
The treatment of resistant neuroblastoma with 131I-mIBG: alternative methods of dose prescriptionS L Fielding, M A Flower, D M Ackery, et al.
Cancer Metastasis Reviews|September 1, 1996
Chemoprotection of normal tissues by transfer of drug resistance genesJ A Rafferty, I Hickson, N Chinnasamy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1992
Phase I/II study of iodine 131 metaiodobenzylguanidine in chemoresistant neuroblastoma: a United Kingdom Children's Cancer Study Group investigationL S Lashford, I J Lewis, S L Fielding, et al.
European Journal of Nuclear Medicine|January 1, 1988
The biodistribution and pharmacokinetics of meta-iodobenzylguanidine in childhood neuroblastomaL S Lashford, J Moyes, R Ott, et al.
Pageof 4